Latest filing published 20 Nov 2023 for Navidea Biopharmaceuticals, INC.. Read the official filing
No signal scores available.
All filings by Jill Stefanelli on record concern Navidea Biopharmaceuticals, Inc. In total, 2 filings cover trades dated from 8 June 2023 to 16 November 2023.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 20 November 2023 with a share grant in Navidea Biopharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations